DXB vs OPT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

OPT

OPTHEA FPO [OPT]

40LOW

Score Breakdown

DXB OPT
Technical
45
50
Catalyst
48
50
Sentiment
50
50
Fundamental
82
24
Momentum
36
19
Risk Gate
50
35

Key Metrics

DXB Metric OPT
$141.1MMarket Cap$17.8M
3.2MAvg Volume (20d)23.6M
N/AShort InterestN/A
$0.66552-Week High$0.600
$0.15852-Week Low$0.012
+2.1%Daily Change+8.3%
$0.240Entry Price$0.013
-594.5%ROEN/A
-219.9%Profit MarginN/A

Active Signals

DXB Signals

Watch out — volume is flowing out even as price holds up. Distribution pattern
Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
4C filed 2026-04-29
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (15% of range)

OPT Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
Stochastic just turned bullish from a low level — early reversal sign
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading below both moving averages — the trend is working against this one
Drifting lower — down 7.1% over the last 5 days
Lagging the Small Ords index — relative strength of 0.87, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.0 quarters)

Ask Scout AI to compare DXB and OPT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → OPT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).